PUBLISHER

Portfolio, Helen Gavaghan, 1991 to 1995

Sole tradership

1995

1994

1993

1992

1991

1991
NASA hunt for missing satellite money, New Scientist 132 (1795): 22-22 Nov 16.
Soviets search for partners in space, New Scientist 132 (1793): 17-18 Nov 2.
Will Europe's spaceplane leave the drawing board, New Scientist 132 (1791): 13-13 Oct 19.
Satellites strike back against solar flares, New Scientist 132 (1791): 23-23 Oct 19.
Navigating the northeast passage, New Scientist 132 (1791): 23-23 Oct 19.
Hotol hitches a lift from the Soviets, New Scientist 132 (1791): 23-23 Oct.
NASA told to think small on climate satellites, New Scientist 132 (1789): 11-11 Oct 5.
Gamma rays burst onto an unsuspecting world, New Scientist 132 (1789): 18-18 Oct 5.
United States cities breathe easier with oxygenated fuels, New Scientist 131 (1788): 27-27 Sep 28.
United States looks forward to Soviet space sale, New Scientist 131 (1787): 17-17 Sep 21.
Satellite to probe the roof of the sky, New Scientist 131 (1786): 27-27 Sep 14.
Hubbles gyros put NASA in a spin, New Scientist 131 (1780): 7-7 Aug 3.
Journal rekindles row over Silver Springs monkeys, New Scientist 131 (1776): 15-15 Jul 6.
Mission to Mars will need nuclear power, New Scientists 130 (1774): 15-15 Jun 22.
NASA pays high price to save space station, New Scientist 130 (1765): 23-23 Apr 20.
Hubble mirror image heads for the skies, New Scientist 130 (1763): 22-22 Apr 6.
Intercepting the messenger of cosmic violence, New Scientist 129 (1762): 12-13 Mar 30.
Cut price space station runs out of steam, New Scientist 129 (1761): 13-13 Mar 23.
Infrared - the astronomer's favourite wavelength, New Scientist 129 (1761): 16-16 Mar 23.
Congress to smooth path for nuclear power, New Scientist 129 (1760): 12-12 Mar 16.
Tobacco warning, New Scientist 129 (1757): 18-18 Feb 23.
TOP

1992
Cleaned up probe on course for Mars, New Scientist 135 (1834): 5-5 Aug 15.
NASA at the end of its tether over reel problems, New Scientist 135 (1834): 5-5 Aug 15.
Electric power from satellite on a string, New Scientist 135 (1832): 19-19 Aug 1.
NASA cuts back to win over Congress, New Scientist 134 (1823): 19-19 4-4 May 30.
Zoo animals do it better, New Scientist 134 (1823): 4-4 May 30.
Satellites peer through window to the galaxy, New Scientist 134 (1823): 20-20 May 30.
NASA celebrates its spacewalking endeavours, New Scientist 134 (1822): 8-8 May 23.
Wobbly start for space salvage crew, New Scientist 134 (1821): 9-9 May 16.
Animal experiments the American Way, New Scientist 134 (1821): 4 pages, May 16
Galactic neighbour may harbor a black hole, New Scientist 134 (1818): 16-16 Apr 25.
Green research gains ground in America, New Scientist 134 (1817): 8-8 Apr 18.
Nervous NASA awaits its new supremo, New Scientist 133 (1813): 13-13 Mar 21.
Washington takes a stand on biotechnology, New Scientist 133 (1811): 10-10 Mar 7.
Plans for NASA database too vague, New Scientist 133 (1811): 22-22 Mar 7.
NASA resignation leaves room at the top, New Scientist 133 (1809): 11-11 Feb 22.
Bush budget boosts civil science, New Scientist 133 (1807): 14-14 Feb 8.
TOP

1993
UFO spotters get clean bill of health, New Scientist 140 (1898): 5-5 Nov 6.
Will cash cut backs spell the end for freedom, New Scientist 137 (1865): 6-6 Mar 20.
Clinton plans technology push to boost growth, New Scientist 137 (1864): 7-7 Mar 13.
Much of this year was spent in tracking down new sources for my book, Something New Under the Sun ...

1994
NIH should rethink pricing clause, Nature 372 (6506): 488-488 Dec 8.
Fetal gene therapy under the micrsocope - as US bans embryos for research, Nature 372 (6506): 490-490 Dec 8.
ORI finds Imanishi-Kari guilty of misconduct, proposes 10-year ban, Nature 372 (6505): 391-391 Dec 1 1994.
NIH seeks bids for vector centers for gene therapy, Nature 372 (6504): 306-306 Nov 24.
Researchers face delay in supplies of RU486, Nature 372 (6503): 209-209 Nov 17.
Varmus speaks out on need to boost clinical research, Nature 372 (6502): 118-118 Nov 10.
Tunisian Institute to tackle secrets of Malaria genome, Nature 371 (6500): 732-732 Oct 27.
Study proposed on integrity of published data, Nature 371 (6500): 733-733 Oct 27.
Gene advisory group switches focus to ethical issues, Nature 371 (6497): 468-468 Oct 6.
NIH gets the green light on embryo research, Nature 371 (6496): 370-370 Sept 29.
Koop may set up new center for alternative medicine, Nature 370 (6491): 591-591 Aug 25.
Search launched for lowest addictive nicotine level, Nature 370 (6489): 402-402 Aug 11.
Lack of behaviour studies is hampering AIDs prevention, Nature 370 (6488): 316-316 Aug 4.
Reasonable pricing may be dropped from NIH deals, Nature 370 (6487): 238-238 Jul 28.
Peer Review - NIH urged to streamline bids, Nature 370 (6486): 170-171 Jul 21.
FDA claims nicotine levels were manipulated, Nature 369 (6483): 696-696 Jun 30.
Trials must compete for new funds, Nature 396 (6481): 515-515 Jun 16.
Doubts greet violence research funding plea..., Nature 369 (6480): 430-430 Jun 9.
... as NIH tightens up on Academic-Industry deals, Nature 369 (6480): 430-430 Jun 9.
Cautious welcome to NIH peer-review reforms, Nature 369 (6478): 269-269 May 26.
Genetics business booming yet uncertain, Nature 369 (6478): 341-342 May 26.
NIH rejects Persian Gulf Syndrome, Nature 369 (6475): 8-8 May 5.
Cancer Institute to tighten control of trials, Nature 368 (6473): 679-679 Apr 21.
Kessler adds heat to smoke debate, Nature 368 (6470): 382-382 Mar 31.
TOP

1995
Commission Redefines Ethical Research Practices, Nature Medicine 1(9): 859-860 Sept.
The Whistle-Blowers' view, Nature Medicine 1(9): 859-859 Sept.
Waiving informed consent for unconscious patients, Nature Medicine 1 (7): 612-612 July.
Did you know?, Nature Medicine 1 (4): 292-292 Apr.
Industry sceptical on new gene therapy review, Nature Medicine 1 (4): 292-292 Apr.
Clinical research and the need for follow up, Nature Medicine 1 (8): 727-727 Aug.
Health insurance debate stirs trouble for genetic testing, Nature Medicine 1 (8): 733-733 Aug.
Senators voice frustration, White House proposes reform of FDA, Nature Medicine 1 (5): 390-390 May.
A shot in the arm for gene therapy company, Nature Medicine 1(5): 392-392 May.
A prescription for clinical research, Nature Medicine 1 (6): 496-496 Jun.
New oversight for peer review, Nature Medicine 1 (6): 498-498 Jun.
Embryo research tests NIHS mettle, Nature Medicine 1 (1): 5-6 Jan.
Future perfect or imperfect, Nature Medicine 1 (3): 186-187 Mar.
NIH drops reasonable pricing clause, Nature 374 (6524): 669-669 Apr.
Congress turns spotlight on US drug approval agency, Nature 374 (6523): 582-582 Apr 13.
NIH wins patent on basic technique covering all ex-vivo gene therapy, Nature 374 (6521): 393-393 Mar 30.
US lead falters in technology race, Nature 374 (397-397): Mar 30.
NIH to review priorities in readiness for future cuts, Nature 374 (6519): 202-202 Mar 16.
Gene-therapy approval may be rocky road for industry, Nature 374 (6519): 202-202 Mar 16.
US sets up new bioethics advisory board, Nature 374 (6519): 202-202 Mar 16.
AIDS activists seek speedy access to protease drugs --- as companies plan combination trials, Nature 374 (6517): 4-4 Mar 2 1995.
NIH resolves dispute on cancer gene patent, Nature 373 (6516): 649-649 Feb 23.
Medical schools fight their corner, Nature 373 (6516): 649-649 Feb 23.
NIH in line with expectations, Nature 373 (6514): 461-461 Feb 9.
Smithsonian to study museums role after dropping A-bomb exhibition, Nature 373 (6513): 371-371 Feb 2.
AIDs activists fail to block reasonable pricing reform, Nature 373 (6512): 272-272 Jan 26.
Clinical trials face lack of minority-group volunteers, Nature 373 (6511): 178-178 Jan 19.
TOP

*
*